Genprex, Inc. (GNPX) is a pharmaceutical preparations company incorporated in TX, listed on the Nasdaq. With a market capitalization of $5 million, Genprex, Inc. is a micro-cap company. The stock currently trades at $1.97, down 1.50% today, with a 52-week range of $1.71–$55.00.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | $-5.34 | +76.3% | |
| 2023 | — | $-22.56 | -4412.0% | |
| 2022 | — | $-0.50 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-04-01 | 0001437749-25-010311 | SEC ↗ |
| 2023-12-31 | 2024-04-01 | 0001437749-24-010426 | SEC ↗ |
| 2022-12-31 | 2023-03-31 | 0001437749-23-008847 | SEC ↗ |
| 2021-12-31 | 2022-03-30 | 0001437749-22-007680 | SEC ↗ |
| 2020-12-31 | 2021-03-26 | 0001437749-21-007317 | SEC ↗ |
| 2019-12-31 | 2020-03-30 | 0001437749-20-006522 | SEC ↗ |
| 2018-12-31 | 2019-04-01 | 0001564590-19-010279 | SEC ↗ |
| 2017-12-31 | 2018-04-17 | 0001564590-18-008342 | SEC ↗ |